| RS1596223833 |
BLM
|
Health Risk |
Conflicting classifications of pathogenicity |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS1596227700 |
NTHL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 3, Hereditary cancer-predisposing syndrome |
| RS1596227962 |
NTHL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1596228957 |
BLM
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Bloom syndrome |
| RS1596229075 |
BLM
|
Health Risk |
Conflicting classifications of pathogenicity |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS1596229797 |
BLM
|
Health Risk |
Conflicting classifications of pathogenicity |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS1596229894 |
BLM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Bloom syndrome |
| RS1596230118 |
BLM
|
Health Risk |
Pathogenic |
Bloom syndrome, Bloom syndrome |
| RS1596232266 |
BLM
|
Health Risk |
Pathogenic |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS1596233685 |
TSC2
|
Health Risk |
Likely pathogenic |
— |
| RS1596234235 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS1596235791 |
BLM
|
Health Risk |
Pathogenic |
Bloom syndrome, Bloom syndrome |
| RS1596238148 |
BLM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Bloom syndrome |
| RS1596247721 |
PAM16
|
Health Risk |
Pathogenic |
Autosomal recessive spondylometaphyseal dysplasia, Megarbane type |
| RS1596250255 |
BLM
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Bloom syndrome |
| RS1596250472 |
BLM
|
Health Risk |
Pathogenic |
Bloom syndrome, Bloom syndrome |
| RS1596252105 |
ALG1
|
Health Risk |
Pathogenic |
Congenital disorder of glycosylation, ALG1-congenital disorder of glycosylation |
| RS1596252196 |
ALG1
|
Health Risk |
Likely pathogenic |
Congenital disorder of glycosylation, Congenital disorder of glycosylation |
| RS1596252279 |
BLM
|
Health Risk |
Pathogenic |
Bloom syndrome, Bloom syndrome |
| RS1596256204 |
ALG1
|
Health Risk |
Likely pathogenic |
Congenital disorder of glycosylation, Congenital disorder of glycosylation |
| RS1596257782 |
ALG1
|
Health Risk |
Pathogenic |
ALG1-congenital disorder of glycosylation, ALG1-congenital disorder of glycosylation |
| RS1596259554 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1596259672 |
ALG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital disorder of glycosylation, ALG1-congenital disorder of glycosylation |
| RS1596259720 |
TSC2
|
Health Risk |
Likely pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1596259789 |
BLM
|
Health Risk |
Conflicting classifications of pathogenicity |
Bloom syndrome, Bloom syndrome |
| RS1596259860 |
BLM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1596261161 |
ALG1
|
Health Risk |
Likely pathogenic |
Congenital disorder of glycosylation, Congenital disorder of glycosylation |
| RS1596261208 |
ALG1
|
Health Risk |
Pathogenic |
Congenital disorder of glycosylation, ALG1-congenital disorder of glycosylation |
| RS1596261268 |
ALG1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital disorder of glycosylation, ALG1-congenital disorder of glycosylation |
| RS1596263036 |
ALG1
|
Health Risk |
Pathogenic |
ALG1-congenital disorder of glycosylation, ALG1-congenital disorder of glycosylation |
| RS1596264554 |
MNS1
|
Health Risk |
Likely pathogenic |
Situs inversus, Heterotaxy |
| RS1596265482 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1596267627 |
BLM
|
Health Risk |
Pathogenic/Likely pathogenic |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS1596268270 |
BLM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1596270677 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1596270787 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS1596270815 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1596273579 |
BLM
|
Health Risk |
Conflicting classifications of pathogenicity |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS1596273687 |
BLM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Bloom syndrome |
| RS1596273746 |
BLM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1596275276 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1596275494 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1596277148 |
ROGDI
|
Health Risk |
Pathogenic |
Amelocerebrohypohidrotic syndrome, Amelocerebrohypohidrotic syndrome |
| RS1596278377 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 2 |
| RS1596288578 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1596288988 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, TSC2-related disorder |
| RS1596298137 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1596298721 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1596303148 |
TPM1
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy 1, Hypertrophic cardiomyopathy 1 |
| RS1596303442 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 2 |
| RS1596303739 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1596303814 |
TSC2
|
Health Risk |
Likely pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1596305980 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1596307300 |
TSC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1596312554 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1596317691 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1596317714 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1596318782 |
FANCI
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1596324325 |
FANCI
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group I |
| RS1596330487 |
DIAPH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 1, Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome |
| RS1596335566 |
DIAPH1
|
Health Risk |
Likely pathogenic |
Macrothrombocytopenia, Hearing impairment |
| RS1596335963 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1596336374 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1596336436 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1596336945 |
FANCI
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1596339533 |
DIAPH1
|
Health Risk |
Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 1, Autosomal dominant nonsyndromic hearing loss 1 |
| RS1596341256 |
TRIP4
|
Health Risk |
Pathogenic |
— |
| RS1596342515 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1596342841 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Rhabdomyoma |
| RS1596343067 |
FANCI
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group I, Fanconi anemia complementation group I |
| RS1596343922 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1596344279 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1596345229 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 2 |
| RS1596348299 |
VPS33B
|
Health Risk |
Pathogenic |
Cholestasis, progressive familial intrahepatic |
| RS1596348339 |
POLG
|
Health Risk |
Likely pathogenic |
— |
| RS1596348443 |
POLG
|
Health Risk |
Pathogenic/Likely pathogenic |
Sensory ataxic neuropathy, dysarthria |
| RS1596348470 |
FANCI;POLG
|
Health Risk |
Likely pathogenic |
Progressive sclerosing poliodystrophy, Progressive sclerosing poliodystrophy |
| RS1596348547 |
POLG
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive sclerosing poliodystrophy, Progressive sclerosing poliodystrophy |
| RS1596350117 |
POLG
|
Health Risk |
Likely pathogenic |
Progressive sclerosing poliodystrophy, Mitochondrial DNA depletion syndrome 4b |
| RS1596350386 |
POLG
|
Health Risk |
Pathogenic |
Progressive sclerosing poliodystrophy, 6 conditions |
| RS1596350476 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Isolated focal cortical dysplasia type II, Lymphangiomyomatosis |
| RS1596350698 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1596351849 |
MYO1E
|
Health Risk |
Likely pathogenic |
Focal segmental glomerulosclerosis 6, Focal segmental glomerulosclerosis 6 |
| RS1596352071 |
POLG
|
Health Risk |
Likely pathogenic |
Progressive sclerosing poliodystrophy, Progressive sclerosing poliodystrophy |
| RS1596352300 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1 |
| RS1596352762 |
POLG
|
Health Risk |
Likely pathogenic |
Progressive sclerosing poliodystrophy, Progressive sclerosing poliodystrophy |
| RS1596352895 |
POLG
|
Health Risk |
Pathogenic/Likely pathogenic |
Sensory ataxic neuropathy, dysarthria |
| RS1596353095 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive sclerosing poliodystrophy, POLG-related disorder |
| RS1596354607 |
POLG
|
Health Risk |
Pathogenic |
Progressive sclerosing poliodystrophy, Progressive sclerosing poliodystrophy |
| RS1596356248 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1596356291 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1596356585 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1596356898 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1596358408 |
POLG
|
Health Risk |
Likely pathogenic |
Sensory ataxic neuropathy, dysarthria |
| RS1596358564 |
VPS33B
|
Health Risk |
Likely pathogenic |
Arthrogryposis, renal dysfunction |
| RS1596359384 |
POLG
|
Health Risk |
Pathogenic |
mitochondrial hepatopathy, mitochondrial hepatopathy |
| RS1596359629 |
POLG
|
Health Risk |
Pathogenic |
Progressive sclerosing poliodystrophy, Progressive sclerosing poliodystrophy |
| RS1596360430 |
POLG
|
Health Risk |
Pathogenic |
Progressive sclerosing poliodystrophy, Progressive sclerosing poliodystrophy |
| RS1596360976 |
TPM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Dilated cardiomyopathy 1Y |
| RS1596366489 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |